Rare Disease Specialist - Northeast
Disc Medicine
Summary
As a Rare Disease Specialist (RDS) at Disc Medicine, you will play a pivotal role in our inaugural commercial launch. In this highly visible, field-based role, you will translate cutting-edge science into impactful engagements with healthcare professionals (HCPs) who treat patients with serious hematologic conditions. Representing a patient-centric, scientifically rigorous organization, you will help shape the treatment landscape for rare blood disorders. You will be responsible for executing a salesforce-driven lead program, strengthening existing relationships, forging new ones, and driving awareness and adoption of novel therapies.
Job description
Position Overview
As a Rare Disease Specialist (RDS) at Disc Medicine, you will play a pivotal role in our inaugural commercial launch. In this highly visible, field-based role, you will translate cutting-edge science into impactful engagements with healthcare professionals (HCPs) who treat patients with serious hematologic conditions. Representing a patient-centric, scientifically rigorous organization, you will help shape the treatment landscape for rare blood disorders. You will be responsible for executing a salesforce-driven lead program, strengthening existing relationships, forging new ones, and driving awareness and adoption of novel therapies.
Responsibilities
- Execute a salesforce-driven lead program, including management of qualified leads, territory call plans, target lists, and conversion funnels.
- Engage HCPs (e.g., hematologists, dermatologists, academic institutions, rare disease clinics) with compelling, evidence-based messaging aligned with lead generation campaigns.
- Maintain up-to-date expertise in disease pathophysiology, clinical data, and competitive dynamics in the rare disease space.
- Provide real-time feedback on insights, unmet needs, and content performance to Medical Affairs and Commercial Operations.
- Collaborate cross-functionally with Marketing, Medical Affairs, Patient Access, and Sales Operations to enhance campaign strategy, tools, and messaging.
- Meet or exceed KPIs related to lead conversion, KOL engagement, call frequency, and new account development.
- Represent the company at national scientific conferences, advisory, and professional meetings as needed.
- Ensure all activities adhere to regulatory, legal, and compliance standards, including the Sunshine Act, FDA guidelines, and internal policies.
- Accurately document all HCP interactions and expenditures in a timely manner in accordance with federal and state regulations.
- Uphold the highest ethical standards in all engagements, prioritizing scientific integrity and patient welfare.
Requirements
- Bachelor's degree required; advanced degree (MBA, MS, or PhD) preferred.
- Minimum of 10 years of pharmaceutical or biotech sales, with a focus on rare diseases, rare hematology or rare dermatology.
- Experience launching early-stage therapies in a nascent market or building lead networks for pre-commercial developing market products strongly preferred.
- Proven track record of achieving sales goals and driving adoption of specialty products across-specialties.
- Existing HCP and network relationships management capabilities within assigned geography.
- Strong account management capabilities.
- Exceptional communication and presentation skills with the ability to translate complex clinical data into compelling, value-driven narratives.
- Solid understanding of payer landscape, patient-access programs, and reimbursement models in rare disease treatment.
- Deep understanding of compliance and regulatory, including the Sunshine Act, HIPPA and FDA promotional guidelines.
- Self-motivated, highly organized, and adept at thriving in a fast-paced, scaling commercial environment.
- Willingness to travel up to ~50% nationally, with flexibility for regional meetings and conferences.
Requirements
- Bachelor's degree required
- Advanced degree (MBA, MS, or PhD) preferred
- Minimum of 10 years of pharmaceutical or biotech sales experience
- Focus on rare diseases, rare hematology or rare dermatology
- Experience launching early-stage therapies in a nascent market or building lead networks for pre-commercial developing market products strongly preferred
- Proven track record of achieving sales goals and driving adoption of specialty products across-specialties
- Existing HCP and network relationships management capabilities within assigned geography
- Strong account management capabilities
- Exceptional communication and presentation skills
- Ability to translate complex clinical data into compelling, value-driven narratives
- Solid understanding of payer landscape, patient-access programs, and reimbursement models in rare disease treatment
- Deep understanding of compliance and regulatory, including the Sunshine Act, HIPPA and FDA promotional guidelines
- Self-motivated, highly organized, and adept at thriving in a fast-paced, scaling commercial environment
- Willingness to travel up to ~50% nationally
Benefits
- Comprehensive benefits
- Competitive compensation packages
- Flexible work environment
Company overview
Disc Medicine is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients with serious hematologic disorders. Headquartered in Watertown, Massachusetts, the company focuses on discovering, developing, and commercializing novel treatments that target fundamental pathways of red blood cell biology, specifically heme biosynthesis and iron homeostasis. With a specialized focus on hematology, Disc Medicine is building a unique portfolio of innovative, first-in-class therapeutic candidates designed to address a wide spectrum of blood disorders ranging from rare genetic conditions like erythropoietic protoporphyria (EPP) to complex blood cancers such as myelofibrosis and polycythemia vera. The company's pipeline includes promising candidates like bitopertin for EPP and DISC-0974 for anemia of myelofibrosis, with several programs advancing through clinical trials. Disc Medicine operates with a team of experienced scientists and industry veterans who bring deep expertise in drug development from discovery through commercialization, demonstrating a commitment to scientific rigor and patient-focused innovation in the hematology space.